Vaxil BioTherapeutics Israeli Company

Vaxil BioTherapeutics is a clinical-stage company developing immunotherapeutic products, including long peptide vaccines and antibodies to treat cancer and infectious diseases. Vaxils products are derived from its fully owned proprietary technology, VaxHit, which uses the signal peptide domains in selected targets as core antigens.